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Mycobacterium tuberculosis (M. tuberculosis), an intracellular pathogenic Gram-positive 
bacterium, is the cause of tuberculosis (TB), a major worldwide human infectious disease. 
The innate immune system is the first host defense against M. tuberculosis. The recog-
nition of this pathogen is mediated by several classes of pattern recognition receptors 
expressed on the host innate immune cells, including Toll-like receptors, Nod-like recep-
tors, and C-type lectin receptors like Dectin-1, the Mannose receptor, and DC-SIGN. M. 
tuberculosis interaction with any of these receptors activates multiple signaling pathways 
among which the protein kinase C, the MAPK, and the NFκB pathways have been widely 
studied. These pathways have been implicated in macrophage invasion, M. tuberculosis 
survival, and impaired immune response, thus promoting a successful infection and 
disease. Interestingly, the Wnt signaling pathway, classically regarded as a pathway 
involved in the control of cell proliferation, migration, and differentiation in embryonic 
development, has recently been involved in immunoregulatory mechanisms in infectious 
and inflammatory diseases, such as TB, sepsis, psoriasis, rheumatoid arthritis, and 
atherosclerosis. In this review, we present the current knowledge supporting a role for 
the Wnt signaling pathway during macrophage infection by M. tuberculosis and the 
regulation of the immune response against M. tuberculosis. Understanding the cross 
talk between different signaling pathways activated by M. tuberculosis will impact on the 
search for new therapeutic targets to fuel the rational design of drugs aimed to restore 
the immunological response against M. tuberculosis.
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iNTRODUCTiON
Mycobacterium tuberculosis (M. tuberculosis) is the cause of human tuberculosis (TB), which is 
regarded as one of the most harmful pathogen, just behind HIV, that is responsible for more deaths 
than any other microorganism. The WHO in 2015 estimated that 1/3 of the planet’s population 
harbor this bacterium, yet only 2–23% will develop disease during their lifespan. M. tuberculosis is a 
Gram-positive bacterium that spreads by aerosols. Upon entry into the lungs, M. tuberculosis infects 
alveolar macrophages, a process mediated by a variety of receptors expressed on the surface of these 
phagocytic cells (1). Receptors expressed in macrophages involved in M. tuberculosis internalization 
include complement receptors (2), C-type lectin receptors, dectin-1, mannose receptors, scavenger 
FigURe 1 | Mycobacterium tuberculosis (M. tuberculosis) recognition by immune receptors. During the infection, several classes of PPRs such as the Fcγ 
receptor, the Scavengers, and Mannose receptors recognize M. tuberculosis. Mycobacterium interaction with these receptors activates the protein kinase C 
pathway. This pathway is implicated in the cytoskeletal arrangements, macrophage invasion, and M. tuberculosis survival. Upon invasion of the macrophage by M. 
tuberculosis, coronin-1a is recruited to the mycobacterial phagosome leading to the induction of calcium fluxes, thus resulting in calcineurin activation, which blocks 
the phagosome–lysosome fusion by an unknown mechanism.
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receptors (3–5), CD14 (6), CD43 (7), and lung surfactant protein 
A (8). However, results obtained from studies using null mice 
for the expression of any of these receptors indicate that none of 
them are essential for M. tuberculosis macrophage invasion (9). 
Likewise, none of these receptors confer a survival advantage for 
M. tuberculosis (10). The engagement of these receptors on the 
macrophage cell surface normally would result in the activation 
of different signaling pathways that lead to the destruction of 
the invading pathogen. However, the M. tuberculosis success as 
an intracellular pathogen resides in the manipulation of these 
signaling pathways by several mechanisms to avoid bactericidal 
activities of the host macrophages and survive inside the cell host 
(11–14). Accordingly with the fact that, most of the receptors 
engaged by M. tuberculosis upon the first contact with the mac-
rophage activate proteins of the protein kinase C (PKC) family 
as well as calcium mobilization (Figure 1), among other known 
mechanisms involved in blocking phagosome-lysosome fusion, 
recently it was shown that Mycobacterium bovis (M.  bovis) 
promotes the coating of the phagosome with coronin-1a, 
which leads to the induction of calcium fluxes activating the 
calcium-dependent phosphatase calcineurin. Upon M.  bovis 
infection, coronin-1a-deficient macrophages show impaired 
calcium mobilization and calcineurin activation, resulting in 
mycobacterial destruction. Consistent with this, preventing 
calcium mobilization, with calcium chelators, or inhibiting cal-
cineurin activation in wild-type macrophages reduces M. bovis 
proliferation and survival (1). Therefore, these data suggest that 
M. tuberculosis-dependent inhibition of phagosome–lysosome 
fusion involves the engagement of multiple receptors that lead 
to dephosphorylation of proteins regulating phagosome matu-
ration (15). Nonetheless, the molecular mechanism by which 
coronin-1a leads to calcium mobilization or whether coronin-1a 
is subjected to regulation by any of the kinases activated by 
M. tuberculosis upon interaction with its plethora of receptors 
remain to be defined.
In addition to the signaling pathways activated by M. tubercu-
losis that allow macrophage invasion and survival, M. tuberculosis 
also activates numerous signaling pathways promoting cytokines 
and chemokines expression. Among those, pro-inflammatory 
cytokines like tumor necrosis factor (TNF), interleukin-1β 
(IL-1β), and interleukin-6 (IL-6) are secreted few hours after 
macrophage infection and precedes anti-inflammatory cytokine 
production, including transforming growth factor β (TGF-β) and 
interleukin-10 (IL-10) (Figure  2) (16). The production of the 
inflammatory cytokines and chemokines at early stages of the 
infectious process is crucial for the recruitment of neutrophils, 
FigURe 2 | The pro-inflammatory and anti-inflammatory cytokines’ genes activated by Mycobacterium tuberculosis (M. tuberculosis). Pro-
inflammatory (left). Interaction of M. tuberculosis with TLR2, Dectin-1, and Fcγ receptors activates NFκB and nuclear factor of activated T cells, which promotes 
transcription of genes such as tumor necrosis factor, IL-6, and IL-1β. Anti-inflammatory (right). Interaction of M. tuberculosis to TLR-2 and Dectin-1 through different 
mechanisms induces the activation of the transcription factors CREB, AP-1, Sp1, and STAT3, which initiates the transcription of genes such as IL-10, TGF-β, and 
IL-22.
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macrophages to the lung, and later on for the recruitment of 
activated T cells. Depending on the final balance between pro- 
and anti-inflammatory cytokines, the host can either assemble 
a response that eliminates the infection or result in granuloma 
formation, thus controlling the infection without bacterial 
elimination (17). Different experimental evidence suggests 
that IL-10 expression is critical for mycobacterium survival, 
granuloma formation, and attenuation of the inflammatory 
response. Transgenic mice expressing human IL-10 specifically 
in the lungs showed increased bacterial burden in Mycobacterium 
avium (M. avium)-containing granulomas. This correlated with 
decreased pro-inflammatory cytokines’ levels, such as TNF and 
IL-12 [reviewed in Ref. (18)].
Thus, M. tuberculosis infection depends on the mycobacterial 
ability to hijack different macrophage signaling pathways, at the 
early stages of infection to avoid its destruction, and at the later 
stages of infection to alter the cytokine profile to attenuate the 
adaptive immune response. In addition to the well-characterized 
pathways involved in these processes, like the PKC, MAPK, 
NFκB and JAK/STATs pathways (Figures 1 and 2), cumulative 
experimental evidence point out a role for the Wnt/β-catenin 
pathway during M. tuberculosis infection. Here, we will discus 
the molecular mechanism by which M. tuberculosis activates the 
Wnt/β-catenin pathway and its role during infection.
THe wnt SigNALiNg PATHwAYS
The Wnt signaling pathway has been extensively studied and 
reviewed (19–23). This signaling pathway is an ancient and 
highly conserved signaling mechanism and involves important 
molecular cascades that regulate cell fate throughout lifespan (19, 
24). The Wnt signaling pathway has been generally associated 
with cellular proliferation, differentiation, apoptosis, motility, 
and polarization of cells, in invertebrates and mammals (25). 
Mutations in molecules controlling this pathway that result in 
constitutive activation of the pathway may lead to colon cancer, 
hair follicle tumors, and leukemia (26). However, the role of Wnt 
signaling in the immune response against pathological bacteria 
is poorly understood.
The Wnt/β-catenin network was first identified in 1982 with 
the discovery of the proto-oncogene Int1 in mice (27). Later in 
1987, the segment polarity gene wingless, the Drosophila mela-
nogaster homolog of Int1 was cloned and shown to be required for 
proper wing formation (28). Until now, there are three different 
FigURe 3 | The canonical wnt signaling pathway. In the absence of Wnt ligands, β-catenin interacts with a degradation complex, which is formed by Axin, 
APC, GSK3, and CK1. In this complex, β-catenin is phosphorylated by GSK3 and by CK1 leading to ubiquitylation and subsequently degradation of β-catenin in the 
proteasome. When β-catenin is degraded, Groucho, which is a co-repressor protein, interacts with LEF1 and TCF. The Groucho/LEF1/TCF complex represses the 
transcription of target genes (left). Wnt ligands interact with the Frizzled receptor, a G protein-coupled receptor, and with the co-receptor LRP. GSK3 and CK1 
induce the phosphorylation of LRP leading to the recruitment of axin and disheveled to the LRP/G protein-coupled receptor complex releasing β-catenin. Then, 
β-catenin is accumulated in the nucleus where it binds to LEF1 and TCF to induce the transcription of specific genes (right).
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characterized Wnt pathways: the canonical pathway or Wnt/β-
catenin (cadherin-associated protein β), which involves β-catenin 
and members of T-cell factor (TCF)/lymphoid enhancer-binding 
factor (LEF) family of transcription factors (TCF/LEF); the 
planar cell polarity (PCP) pathway; and the Wnt/Ca++ pathway 
(29). The ligands involved in the Wnt pathway are soluble factors 
that can be divided into two subclasses: the Wnt1 and Wnt5a. 
The Wnt1 proteins (Wnt1, Wnt2, Wnt3, Wnt3a, Wnt7a, Wnt8a, 
and Wnt10b) (30) participate in the canonical Wnt pathway. On 
the other hand, the Wnt5a proteins (Wnt4, Wnt5a, and Wnt11) 
participate in non-canonical signaling pathway (31).
THe CANONiCAL PATHwAY
The canonical Wnt signaling or Wnt/β-catenin signaling is the 
most and best understood and characterized pathway (Figure 3) 
(29). In the absence of Wnt ligands, cytoplasmic β-catenin is 
phosphorylated on its N-terminal region, first on Ser 45 by 
casein kinase 1 (CK1), and then on Ser33, Ser37, and Thr41 by 
the glycogen synthase kinase 3 β (GSK3β) to create recognition 
sites for β-transducin-repeat-containing protein (βTRCP), lead-
ing to the β-catenin ubiquitylation and preteasomal breakdown, 
preventing in this way its nuclear translocation and Wnt-
dependent gene expression (32). To activate the Wnt/β-catenin 
pathway, the Wnt ligands bind the receptor complex formed by 
the Frizzled (FZD) receptor and the low-density lipoprotein 
receptor-related protein (LRP), leading to the recruitment of 
the protein disheveled (DVL). This recruitment inactivates the 
β-catenin destruction complex, which is conformed by protein 
Axin, tumor-suppressor adenomatous polyposis coli gene 
product (APC), CK1, and GSK3β, thus preventing β-catenin 
phosphorylation by GSK3 and consequently, its proteasomal 
degradation. This, results in β-catenin accumulation and 
translocation to the nucleus where it drives the expression of 
TCF/LEF-dependent genes [c-Myc, CyclinD-1, Axin2, metal-
loproteinases, CD44, peroxisome proliferator-activated receptor 
gamma (PPARγ, etc.)], which are involved in cell proliferation, 
survival, and cell differentiation (31).
FigURe 4 | The non-canonical wnt signaling pathway. Two β-catenin independent Wnt signaling pathways have been reported. The planar cell polarity 
(PCP) pathway is triggered by Wnt5 and Wnt11. Wnt5/11 binds Frizzled leading to the activation of a trimeric G protein that induces the activation of disheveled 
and DAAM. Together these proteins trigger the activation of the small GTPases RHOA and RAC-1 that leads to the activation of the kinases JUN kinase (JNK) 
and ROCK. These signaling pathways are involved in cell adhesion, migration, and cell cytoskeleton organization. The stress response pathway involves the 
activation of JNK, which phosphorylates the transcriptional factors AP-1 and JUN leading to their translocation to the nucleus to regulate gene expression (left). 
The Wnt/Ca2+ signaling pathway is triggered by Wnt5–FZD-2. The activation of this pathway is mediated through G proteins, which induces the phospholipase C 
activation, leading to the hydrolysis of PIP2 into DAG and IP3. The IP3 induces the release of intracellular Ca++, activation of calcineurin, and CAMKII. The active 
calcineurin induces the nuclear factor of activated T cells (NFAT) activation. Intracellular calcium as well as DAG activates protein kinase C (PKC) increasing the 
activity of calcineurin triggering the translocation of the transcriptional factor NFAT to the nucleus. Similarly, PKC induces the activation and translocation of NFκB 
to the nucleus (right).
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NON-CANONiCAL PATHwAYS
The non-canonical Wnt pathway is defined as Wnt or FZD 
receptor-initiated signaling that is independent of β-catenin 
transcriptional function (33). So far, two different non-canonical 
Wnt pathways have been described, the Wnt–Ca++ pathway 
and the PCP pathway (Figure  4) (29). Such classifications are 
not strictly rigid and exclusive as these pathways overlap with 
or intersect one another (33). Wnt5 and Wnt11 participate in 
initializing PCP pathway through FZD and DVL (mammalian 
homolog of Drosophila disheveled) activating trimeric G 
proteins and DVL and DAAM (disheveled-associated activator 
of morphogenesis), which together activate the RHOA (RAS 
homolog gene-family member A)–ROCK (RHO-associated 
coiled-coil containing protein kinase) pathway, that mediates 
cytoskeletal re-organization (34). The DVL–DAAM–RHOA 
complex activates RHOA, resulting in ROCK kinase activation 
(33). In addition to RHOA activation, DVL also activates RAC1 
(Ras-related C3 botulinum toxin substrate 1) leading to the acti-
vation of the JUN kinase stress response pathway, thus influenc-
ing cell shape (29). Hence, the PCP pathway, through regulating 
actin-dependent changes in cytoskeleton, controls cell adhesion 
and migration. Interestingly, in both T and B lymphocytes, it 
has been observed that this pathway can inhibit the canoni-
cal Wnt pathway by downregulating β-catenin levels (35, 36). 
Downstream pathways of DVL regulate the cytoskeleton and cell 
polarity; however, in immune cells, the molecular mechanism 
involved is not clear yet (29).
FigURe 5 | Mycobacterium tuberculosis (M. tuberculosis) inhibits tumor necrosis factor (TNF) through the wnt pathway in a paracrine and autocrine 
manner. Wnt5, Wnt6, and pro-inflammatory cytokines are induced in macrophages in response to mycobacterial infection. Secreted Wnt5 and Wnt6 are 
recognized by FZD receptors expressed on the cell surface of neighboring macrophages, impairing TNF and IL-12 expression. Additionally, TNF released by the M. 
tuberculosis-infected macrophages promotes FZD1 expression in neighboring macrophages, rendering them susceptible to Wnt3 actions, which inhibits TNF 
expression.
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The Wnt–Ca++ signaling pathway can influence the activation 
of both, canonical and non-canonical Wnt pathway. It has been 
proposed that Wnt5 and Frizzled-2 can initiate this pathway 
(37, 38). The Wnt–FZD complex activates phospholipase C 
through a small G protein. This activation leads to cleavage of 
phosphatidylinositol-4-5-biphosphate (PIP2) to diacylglycerol 
(DAG) and inositol triphosphate (IP3). IP3 binding to its receptor 
leads to an increase in intracellular calcium; DAG and calcium 
activates different members of the PKC family. Increased calcium 
levels also lead to activation of the phosphatase calcineurin, 
promoting the activation of the nuclear factor of activated T cells 
(NFAT) (39, 40), that is involved in T-cell receptor-mediated 
activation of interleukin-2 production in T-lymphocytes (29). 
Another connection between the non-canonical Wnt signaling 
pathway and NFAT function involves GSK3β, which through 
NFAT phosphorylation promotes its exit from the nucleus (41) 
and reduces NFAT-dependent gene expression. All together, 
these observations suggest that the non-canonical Wnt signaling 
pathways regulate NFAT-dependent gene expression by different 
mechanisms (29, 41).
wnt SigNALiNg AND iNFLAMMATiON
Recently, the role of Wnt signaling pathway in inflammatory 
processes started to be understood. Wnt signaling can prevent 
or promote inflammation. For example, exposing 3T3-L1 preadi-
pocytes to TNF promotes Wnt10b expression and enhances 
activation of the canonical Wnt pathway, resulting in altered adi-
pocyte differentiation toward an inflammatory phenotype (42). 
However, whether Wnt10b mediates TNF-induced preadipocyte 
differentiation toward the pro-inflammatory phenotype remains 
to be elucidated. Mouse microglial cells upregulate the expres-
sion and release of IL-6, IL-12, and IFNγ in response to Wnt3a 
(43). In contrast, Wnt3a has an anti-inflammatory effect on 
macrophages, while Wnt11 has the same effect on mouse colonic 
cells (44). These data indicate that the Wnt proteins promote 
pro- or anti-inflammatory responses and that this depends on the 
cellular context, the type of insult, and the cytokine environment 
(Figure 5). The fact that cytokines can upregulate Wnt expression 
raises the question of how many of the cellular responses trig-
gered by cytokines are mediated by a paracrine effect mediated 
by Wnt factors and the activation of both the canonical and non-
canonical Wnt pathways?
There is very scant information regarding the role of different 
Wnt members in response to pathogenic bacterial infections and 
in particular on their role in M. tuberculosis infection. Table 1 
summarizes our current knowledge on this matter.
Additionally, the transcription factors that regulate the 
gene expression of the distinct Wnt and FZD family members 
in response to cytokines are largely unknown. Chromatin-
immunoprecipitation-sequencing data from the Encode database 
revealed that transcription factors like FBJ murine osteosarcoma 
viral oncogene homolog (Fos), V-Jun avian sarcoma virus 17 
oncogene homolog (Jun), signal transducer and activator of 
transcription 1 and 2 (STAT1, STAT2) interact with sequences 
located 1,000 base pairs upstream from the transcription start site 
for the genes encoding Wnt2, Fzd1, Fzd2, and Fzd7 (Table 2), and 
thus directly controlling the expression of these genes in response 
TAbLe 1 | The role of the wnt family members in Tb.
wnt homolog Found in Tb 
disease
Roll in Tb infection Pathway Cellular function Model Receptors 
involved
Wnt3a Downregulated Anti-inflammatory 
prevents TB infection
Canonical Necrosis inhibition, promotes apoptosis, inhibits migration, 
promotes cellular adhesion, inhibits TNF secretion in a 
paracrine manner
Mouse (Raw 
cells)
Human (THP-1 
cells) (44–47)
FZD 1
Wnt5a Downregulated/
upregulated
Anti-inflammatory 
promotes TB infection
Non-
Canonical
Promotes phagocytosis, inhibits phagolysosome formation, 
inhibits IL-12 and INFγ production
Mouse (Raw 
cells), human 
(48, 49)
FZD 2,4,7
Wnt6 Upregulated Anti-inflammatory 
promotes TB infection
Non-
canonical
Inhibits TNF production, promotes the formation of foamy 
cells, cellular proliferation, and M2 phenotype
Mouse (50) Unknown
Wnt1, Wnt2, 
Wnt4, Wnt7, 
Wnt8, Wnt10b
Downregulated – – – Mouse (50) FZD 
1,3,4,5,7,8
Wnt10a Upregulated – – – Mouse (50) Unknown
Wnt, wingless/Int factor; TB, tuberculosis; TNF, tumor necrosis factor; IL-12, interleukin-12; INFγ, interferon γ; M2, macrophage alternative activation; FZD, frizzled.
TAbLe 2 | Transcription factors activated by cytokine signaling that 
interact with 5′ regulatory sequences of genes encoding for wnt or Fzd 
receptors.
wnt pathway component Transcription factor associated with 
inflammation
FZD2 STAT3, AP-1, nuclear factor of activated T cells 
(NFAT)
WNT3 STAT3, NFκB, NFAT, LEF1
Wnt8 NFAT, NFκB, STAT5
FZD1 IRF, LEF1, NFκB, NFAT, STAT3, AP-1
Wnt1 NFAT, IRF, NFκB
Wnt2 NFAT, LEF
Wnt4 IRF, NFκB
Wnt5 NFAT, IRF, LEF-1, STAT6, STAT5, NFκB
WNT6 STAT6, NFκB
WNT7 NFκB, NFAT, IRF
Wnt10a STAT6, IRF, NFκB, NFAT, LEF
Wnt10b STAT5, NFκB, NFAT, IRF, AP-1
Data obtained from the Encode project. Based on chromatin immunoprecipitation-
sequencing data including 1,000 bp upstream from the transcription start site.
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to cytokines. Currently, there is no information for the other Wnt 
or FZD family members.
wnt3
Wnt3 is known as a canonical member of the Wnt family. 
Although monocytes and granulocytes express FZD receptors 
(FZD1, 5, and 7), when exposed to Wnt3 in vitro, only mono-
cytes’ transendothelial migration capacity is reduced (51). This 
involves the activation of Wnt/β-catenin pathway and increased 
cell adhesion to endothelial cells (45), hence, suggesting an 
anti-inflammatory role for Wnt3. However, the Wnt/β-catenin 
regulated genes involved in enhanced endothelial cell adhesion 
remain to be identified. In the context of M. tuberculosis infec-
tion, the role of Wnt3 is controversial. In bone marrow-derived 
macrophages, M. tuberculosis H37rv promotes Fzd1 receptor 
gene expression through the TLR-2/MYD88/NFκB pathway; 
M. tuberculosis-induced Fzd1 expression also involves TNF (52). 
Interestingly, INFγ enhances Fzd1 levels on the cell surface of M. 
tuberculosis-infected macrophages. According to its proposed 
anti-inflammatory function, Wnt3 reduced TNF secretion 
but not Tnf gene expression in M. tuberculosis-infected mac-
rophages. This effect is mediated through the canonical pathway, 
since Wnt3 induces β-catenin stabilization and Axin2 expres-
sion (52). Additionally, Wnt3 also promotes the expression of 
Arginase 1 in M. tuberculosis-infected macrophages, which has 
been associated with the anti-inflammatory M2 phenotype (44). 
In the lung epithelia, Wnt3 is expressed constitutively. Although 
M. tuberculosis infection does not alter Wnt3 expression in the 
lung epithelia, it promotes Fzd1 and Fzd5 gene expression while 
reducing the expression of Fzd 3,4, 6–10, this correlates with 
reduced β-catenin protein levels and thus β-catenin-dependent 
gene expression (52). However, whether in vivo M. tuberculosis-
infected macrophages contain increased levels of the Fzd1 recep-
tor on their cell surface and thus making them susceptible to 
Wnt3 activation remains to be determined, since the expression 
levels of the distinct Fzd receptors genes were determined using 
mRNA obtained from total lung homogenates. Nonetheless, the 
Wnt3 negative effect on TNF release by M. tuberculosis-infected 
macrophages suggests anti-inflammatory functions in murine 
macrophages (44). Moreover, it has been described that Wnt3 also 
inhibits IL-6 during mycobacteria infection (44). Interestingly, 
Wnt3 enhances apoptotic cell death in RAW 264.7 macrophage 
infected with M. bovis bacillus Calmette–Guerin (BCG), 
through a mechanism involving the regulation of pro-apoptotic 
and antiapoptotic protein levels. M. bovis BCG-infected mac-
rophages showed increased levels of the pro-apoptotic protein 
Bax and reduced levels of the antiapoptotic protein Mcl-1 in 
response to Wnt3 exposure (46). Thus, by inducing apoptosis of 
infected macrophages, Wnt3 prevents bacterial dissemination. 
Consistent with this idea, another study showed that Wnt3 
reduced the levels of reactive oxygen species (ROS) resulting 
from BCG infection, which correlates with the increase in glu-
tathione levels (Figure 6) (46). However, whether the elevated 
FigURe 6 | wnt3 promotes apoptosis in response to Mycobacterium tuberculosis (M. tuberculosis) infection. Wnt3 plays a protective role in the M. 
tuberculosis infection by preventing bacterial dissemination. On one hand, Wnt3 promotes apoptosis in a caspase-dependent manner, while on the other hand 
inhibits necrosis by promoting glutathione synthase expression (GS) and thus increasing the levels of glutathione (GSH) that in turn results in reduced reactive 
oxygen species and by inhibiting the PARP/AIF pathway.
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glutathione levels induced by Wnt3 result from an increase in 
the enzymatic activity of the enzymes involved in glutathione 
synthesis (gamma-glutamylcysteine synthetase and glutathione 
synthetase) or from increased expression of the genes encoding 
these enzymes, remains to be determined. Together, these results 
suggest that at early stages of the infection, Wnt3 prevents the dis-
semination of infectious mycobacteria by promoting apoptosis 
and reducing necrosis of infected macrophages. However, Wnt3 
promotes the differentiation toward an M2 anti-inflammatory 
phenotype of the infected macrophages that survive, thus 
attenuating the immune response against M. tuberculosis and 
therefore promoting TB.
wnt5
Genomic analyses have shown that macrophages and dendritic 
cells upregulate Wnt5a mRNA levels when exposed to pathogens 
(52, 53). Also, during the differentiation process of monocytes to 
macrophages or dendritic cells, granulocyte macrophage colony-
stimulating factor and IL-4 promote Wnt5a gene expression (51). 
In Raw 264.7 macrophages, M. tuberculosis infection increases 
Wnt5 protein levels. Accordingly, WNT5A and WNT5A recep-
tor FZD5 mRNA levels are induced in human macrophages 
in response to M. tuberculosis and M. avium infection (19). 
M. tuberculosis-dependent WNT5a expression requires TLR2 
signaling and NFκB activation; however, whether M. tuberculosis 
uses the same signaling pathway to induce FZD5 gene expres-
sion remains to be confirmed. Interestingly, human peripheral 
blood mononuclear cells expressing WNT5A and FZD5 mRNA 
were detected in granulomatous lesions in the lungs of M. 
tuberculosis-infected patients (48). Given that the IL-12 produc-
tion by mycobacterium-infected macrophages results from a 
Wnt5a autocrine loop and that activated T cell express FZD5 at 
the mRNA and protein levels (48), these experimental evidence 
indicates that INFγ production by mycobacterial antigen-
stimulated T cells is induced not only by IL-12 but also by the 
interaction of WNT5A with FZD5 receptor expressed on the T 
cell surface. Whether the WNT5A-mediated INFγ production 
in T cells involves the non-canonical Wnt pathway remains to 
be determined. Nonetheless, the paramount role of INFγ in the 
adaptive immune response against M. tuberculosis suggest that 
Wnt5a produced by mycobacterium-infected macrophages also 
play a key role against M. tuberculosis control. However, recently, 
it was shown that M. bovis BCG prevents INFγ-induced mac-
rophage autophagy through a mechanism that involves Wnt5a, 
which enhances the expression of ALOX5 and ALOX15 and 
thus the production of anti-inflammatory lipids (54). Together, 
these results place Wnt5a in the center of the fine balance that is 
required for maintaining the granuloma to avoid bacterial dis-
semination and also to prevent bacterial destruction. Whether 
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Wnt5a is also required for granuloma formation remains to be 
determined.
Although the mechanism by which mycobacteria promotes 
Wnt5 expression remains largely unknown, recently, it has been 
demonstrated that dectin-1 activation through different dectin-1 
ligands, including mycobacteria, results in Wnt5 expression (54). 
Upon dectin-1 engagement, activation of the tyrosine kinase 
SYK and ROS production lead to the inactivation of GSK3 
resulting in β-catenin stabilization and thus Wnt5 expression 
(19). In addition to the functions described above, Wnt5 through 
an autocrine loop activates the non-canonical Wnt pathway, 
resulting in the activation of calcium-activated calmodulin 
kinase (Ca++/CAMKII) pathway and the expression of the 
protein inhibitors of activated STAT (PIAS1) and suppressor 
of cytokine signaling (SOCS1) expression (54). Overexpression 
of PIAS1 and SOCS1 in macrophages dampens TLR-induced 
pro-inflammatory response by reducing the protein levels of 
pivotal TLR adaptors such as IRAK1, IRAK4, and Myd88 (19). 
Accordingly, in vivo activation of dectin-1 receptor with patho-
genic or fungi ligands resulted in an increased mycobacteria 
burden and a concomitant decrease in TLR-triggered pro-
inflammatory cytokines (54). This might also involve impaired 
phagosome–lysosome fusion and bacterial destruction, since 
activation of the non-canonical Wnt pathway by Wnt5 involves 
Ca++ (37, 38), which is required for coronin-1 recruitment to 
the phagosome and calcineurin activation to prevent phago-
some–lysosome fusion (55).
wnt6
In a recent study, Schaale and coworkers showed that 
Wnt6 is expressed in granulomatous lesions in the lung 
of M. tuberculosis-infected mice (50). Wnt6 expression in 
response to mycobacteria is TLR-Myd88-NFκB-dependent. 
Interestingly, foamy macrophage-like cells are the principal 
source of Wnt6. Secreted Wnt6 acts as a paracrine signal on 
neighboring macrophages to promote proliferation and mac-
rophages polarization toward an anti-inflammatory M2 like 
phenotype (50). The Wnt6-induced signal transduction driving 
macrophages proliferation and polarization does not involve 
β-catenin, but relay on G protein-dependent ERK activation 
and c-Myc expression, a pivotal regulator of cell proliferation. 
These observations are consistent with another study showing 
a key role for c-Myc in IL-4-induced alternative activated 
phenotype in human macrophages (56). In this scenario, 
c-Myc directly regulates the expression of genes associated 
with the M2 phenotype like scavenger receptor class B member 
1, ALOX15, and mannose receptor, C-type 1 and indirectly 
regulates the expression of CD206 while strengthening IL-4 
signaling by upregulating STAT6 and PPARγ expression (56). 
It remains to be determined whether these molecules are also 
involved in M2 polarization resulting from Wnt6 exposure. 
Nonetheless, these results point out an important role for 
Wnt6 in promoting macrophages alternative activation within 
the granulomatous lesions, thus providing M. tuberculosis a 
granuloma with an anti-inflammatory microenvironment that 
ensures its survival.
ANOTHeR wnt HOMOLOg
Besides the roles of Wnt3, Wnt5, and Wnt6 in M. tuberculosis 
infection discussed above, the role of other Wnt homologs is 
unknown. In a recent study where Wnt6 was identified as a mol-
ecule expressed exclusively in granulomatous lesions, Schaale 
and coworkers monitored the expression of all Wnt homologs in 
mice infected with M. tuberculosis (50). They found that mRNA 
levels of most Wnt homologs were significantly reduced in the 
course of infection (Wnt2, Wnt2b, Wnt3a, Wnt4, Wnt5, Wnt7a, 
Wnt8a, and Wnt10b), while other homologs were upregulated 
(Wnt1, Wnt6, and Wnt10a) (50). The reduction in the expression 
levels of the majority of the Wnt homologs during mycobacterial 
infection is consistent with a study that indicates that FZD family 
of receptors and the Wnt/β-catenin target gene Axin2 are sig-
nificantly downregulated in the lungs of M. tuberculosis-infected 
mice (44).
In a genetic study made in a Chinese population, 25 poly-
morphisms (SNPs) in the Wnt pathway related to TB risk were 
evaluated. Five polymorphisms were associated with TB sus-
ceptibility: secreted frizzled-related protein (SFRP1) rs4736958, 
CTNNB1 (catenin-β1), rs9859392, rs987055, and rs3864004 
showed decreased TB risk, meanwhile, SFRP1 rs7832767 was 
associated with increased risk (57, 58). According to these results, 
the authors provide evidence that Wnt pathway polymorphisms 
may influence TB susceptibility and host immune response to 
M. tuberculosis, suggesting that these variations could serve as 
novel markers to identify the risk and susceptibility to develop 
TB (57, 58).
NUCLeOTiDe-biNDiNg 
OLigOMeRiZATiON DOMAiN (NOD2) 
MeDiATeS THe ACTivATiON OF THe 
wnt PATHwAY iN ReSPONSe TO 
M. tuberculosis iNFeCTiON?
So far, we have discussed distinct experimental evidences 
that clearly indicate an important role of the Wnt factors on 
the biology of M. tuberculosis-infected macrophages and that 
M.  tuberculosis modulates the expression of these factors and 
their receptors to ensure successful infection. However, whether 
M. tuberculosis triggers the Wnt pathway directly, is still an open 
question. The intracellular pathogen sensor NOD2, which is 
activated by bacterial cell wall components like peptidoglycan, 
specifically by muramyl dipeptide (MDP), has been shown to be 
activated during macrophage infection with M. tuberculosis and 
to synergize with the TLR signaling pathway to promote the pro-
duction of pro-inflammatory cytokines (59–61). Interestingly, 
last year, it was suggested that the activation of NOD2 by MDP 
results in the activation of the Wnt pathway (62). In the pres-
ence of MDP, NOD2 is translocated to the membrane where it 
interacts with the Ly6/PLAUR domain-containing protein 6, 
which has been previously shown to be recruited to the Wnt 
receptor complex and promotes Wnt signaling (63) that results 
in β-catenin nuclear translocation and the expression of the X 
chromosome-linked inhibitor of apoptosis, that in turn activates 
FigURe 7 | Nucleotide-binding oligomerization domain 2 (NOD2) and the activation of the wnt pathway in response to Mycobacterium tuberculosis 
infection. Muramyl dipeptide, derived from the Mycobacterial cell wall at early phases of the macrophages’ infection, triggers NOD2 translocation to the membrane 
where it interacts with the Ly6/PLAUR domain-containing protein 6, which has been previously shown to be recruited to the Wnt receptor complex and promote 
Wnt signaling resulting in β-catenin nuclear translocation and the expression of the X chromosome-linked inhibitor of apoptosis, that in turn activates the NLRP3 
inflammasome resulting in IL-1β maturation.
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the NLRP3 inflammasome leading to IL-1β maturation and 
secretion (62). Thus, it is possible that MDP, derived from the 
mycobacterial cell wall at early phases of the macrophages infec-
tion, triggers NOD2 that activates the Wnt pathway directly even 
in the absence of Wnt factors (Figure 7) to promote caspase-1 
activation and IL-1β production, and probably some of the bio-
logical effects attributed to specific Wnt factors discussed above. 
Nonetheless, this hypothesis remains to be tested.
M. tuberculosis FiNe TUNiNg OF THe wnt 
PATHwAY THROUgH microRNAs 
(miRNAs) RegULATiON
A novel layer of complexity in M. tuberculosis regulatory networks 
controlling host infection, survival, and successful infection has 
recently emerged with the discovery that Mycobacterium regu-
lates the expression of different miRNAs (64). miRNAs regulate 
the protein abundance in any given cell at any given time, thus 
influencing many cellular processes including differentiation, 
proliferation, apoptosis, DNA methylation, DNA repair, and 
provide anti-inflammatory or pro-inflammatory stimuli (65, 66). 
According to this, it is not surprising to find that M. tuberculosis 
positively modulates the expression of miRNAs that target key 
molecules involved in the destruction of the pathogen like apop-
tosis or autophagy and the setting of protective cytokine profiles 
while decreasing the expression of miRNAs whose targets are 
molecules involved in the negative control of these biological 
processes [reviewed in Ref. (67, 68)]. Although we know that the 
miRNA profile expressed by infected macrophages depends on 
the infecting Mycobacterium species (64, 69, 70), the virulence of 
the strain (71), or the stage of the disease (69), the role of those 
miRNAs and the signaling pathway that control their expression 
remains to be elucidated. Nonetheless, at early stage of infec-
tion, inhibition of autophagy and apoptosis and the control of 
the inflammatory response by M. tuberculosis involve different 
miRNAs, some of which could mediate their effect through the 
induction of the Wnt signaling pathway or be regulated directly 
by this pathway (Figure  8). At the onset of infection, miR155 
expression increase in M. tuberculosis-infected macrophages 
(72). The induction of this miRNA may be mediated by the 
activation of NFκB (73); thus, miR155 could impair autophagy 
in M. tuberculosis-infected macrophages through its interaction 
with the 3′ UTRs of different mRNAs encoding for key proteins 
like ULK1, involved in the initiation phase; ATG14, part to the 
BECLIN1 complex that promotes phagophore nucleation; ATG5, 
ATG3, LC3, and GABARAPL1, key players in the elongation and 
maturation steps; and FOXO3, a transcription factor regulating 
FigURe 8 | Mutual regulation between miRNAs and the wnt pathway determine the survival of Mycobacterium tuberculosis (M. tuberculosis)-
infected macrophage and the profile of the inflammatory response. Upon interaction of M. tuberculosis with TLR2 and TLR4, NFκB activation leads to 
increased miR155 levels which, besides its negative effect on autophagy and apoptosis, through the negative modulation of key inhibitors of the Wnt pathway (APC 
and HMG-box transcription factor 1) leads to β-catenin/TCF-mediated expression of miR2, miR125b, miR146b (a target of the Wnt5a signaling pathway), and 
miR29, thus wiping off the pro-inflammatory response. Additionally, miR29 further enhances Wnt signaling by targeting distinct set of Wnt negative regulators 
(Dikkopf-1, Kremen2, and sFRP2).
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the expression of autophagy-related genes, including MAP1LC3, 
ULK1, ATG14, and GABARAPL1 (74). Additionally, miR30a, 
another miRNA expressed in infected macrophages, through 
its interaction with BECLIN1 (75) could also impair autophagy. 
Interestingly miR155, through its negative effect on APC (76) 
and HMG-box transcription factor 1 (77), a strong Wnt pathway 
suppressor and miR30a by blocking PRDMI (78) could induce 
β-catenin/TCF-mediated gene expression, and thus regulate the 
expression of additional miRNAs, like miR21 and miR125b (79) 
and miR146b, which is positively regulated by Wnt5a (80) and 
miR29 (81, 82). miR21 by reducing BCL2 protein levels (83) and 
miR29 by targeting caspase-7 (84) might prevent apoptosis of 
infected macrophages. Additionally, miR29 could also further 
enhance the Wnt signaling pathway by targeting the negative 
regulators of Wnt signaling, Dikkopf-1, Kremen2, and secreted 
frizzled-related protein 2 (sFRP2) (81, 82). While miR146b, 
by targeting IL-1β, IL-6, IRAK1, TRAF6, TNF, TLR4, NFκB1 
(85), and miR21 by negatively regulating IL-12 (86) damp the 
inflammatory response. Additionally, given that the lung epithe-
lium constitutively produces Wnt3 and that the canonical Wnt 
pathway promotes miR125b expression (74), at early stages of M. 
tuberculosis infection, miR125b could also contribute to attenuate 
the inflammatory response by targeting the TNF 3′ UTR (87). 
Together, these results strongly indicate that, at early stages of 
infection, the Wnt pathway controls key macrophage functions 
by modulating miRNAs expression that allows M. tuberculosis 
survival.
A recent study points out that different M. tuberculosis clinical 
strains induced specific macrophage miRNAs expression pat-
terns (69). Macrophages infected with Beijing M. tuberculosis 
strains showed reduced expression of 13 miRNAs compared 
with macrophages infected with non-Beijing M. tuberculosis 
strains. Interestingly, only miR485 showed increased levels in the 
Beijing infected macrophage when compared with non-Beijing 
infected macrophages. Our bioinformatics analysis indicates that 
this miRNA has potential binding sites with thermodynamic 
values that allow specific miRNA/mRNA interactions within 
the 3′ UTR of mRNAs encoding for proteins involved in the 
Wnt pathway (Table 3). A gene ontology analysis revealed that 
through negatively modulating the levels of the SFRP1 and those 
of the Strabismus 1 (STB1), miR485 might positively regulate the 
canonical Wnt pathway. In contrast, miR485 might inhibit the 
non-canonical Wnt pathways by negatively modulating FZD4, 
RAC-1, and PKC (88) (Figure  9). The previous data indicate 
FigURe 9 | The beijing Mycobacterium tuberculosis (M. tuberculosis) strains regulate the wnt pathway during macrophage infection of healthy 
individuals or that of macrophages from patients with active tuberculosis by enhancing miR485 and reducing miR150 levels, respectively. An 
enrichment pathway analysis performed in the WebGestalt platform using the Kyoto Encyclopedia of Genes and Genomes indicates that the miRNA485 potentiates 
the canonical Wnt pathway through negatively regulating protein levels involved in the inhibition of these pathways, while by controlling the protein levels of key 
signaling molecules might inhibit the non-canonical Wnt pathway. In contrast, miR150 has clear inhibitory effect on both the canonical and non-canonical Wnt 
pathway. Thus, through differentially regulating the expression of these two miRNAs, the Beijing M. tuberculosis strains promote the Wnt canonical pathway.
TAbLe 3 | Predicteda miRNA485 target genes.
Target gene Full name Potential binding sitesb ΔΔGc validated
SMAD3 SMAD family member 3 1 –10.15 No
FZD4 Frizzled family receptor 4 1 –9.49 No
RAC1 Ras-related C3 botulinium toxin substrate 1 1 −8.85 No
PPP2R5C Protein phosphatase 2, regulatory subunit B′, γ 1 −15.08 No
SFRP1 Secreted frizzled-related protein 1 1 −8.96 No
SMAD4 SMAD family member 4 1 −9.71 No
CAMK2G Calcium/calmodulin-dependent protein kinase II γ 1 −8.41 No
aTarget prediction was performed using PITA (https://genie.weizmann.ac.il) and TargetScan (http://www.targetscan.org) platforms.
bOnly the potential interaction sites with a ΔΔG ≤ 8 were considered.
cΔΔG values were calculated using PITA.
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that the Beijing M. tuberculosis clinical strains upregulate the 
canonical Wnt pathway by inducing miR485 expression, to 
modulate the macrophage response in order to ensure a suc-
cessful infection.
On the other hand, from the miRNAs negatively regulated 
by the Beijing M. tuberculosis clinical strains in both THP-1 
derived macrophages or in peripheral blood-derived mac-
rophages obtained from TB patients with active disease, miR150 
showed the most prominent reduction (69). Once again, our 
bioinformatic analysis indicated that, this miRNA has numerous 
potential targets in the Wnt pathway (Table  4). According to 
thermodynamic values indicating strong possibilities for specific 
miRNA/mRNAs interactions, from the predicted targets, FZD4 
has been shown to be a bonafide miR150 target (89). The pathway 
analysis of the potential miR150 targets indicates that this mRNA 
might negatively regulate both the canonical and non-canonical 
Wnt pathways (Figure 9). Together, these results suggest that the 
upregulation of miR485 and the negative regulation of miR150 
levels are key events triggered by Beijing M. tuberculosis clinical 
strains to sustain the activation of the canonical Wnt pathway 
TAbLe 4 | Predicteda miRNA150 target genes.
Target gene Full name Potential binding sitesb ΔΔGc validated
MAPK8 Mitogen-activated protein kinase 8 1 −12.38 No
FZD4 Frizzled family receptor 4 1 −8.94 Yes
DAAM2 Disheveled-associated activator of morphogenesis 2 1 −9.87 No
PRKX Protein kinase, X-linked 2 −12.68, −9.81 No
FRAT2 Frequently rearranged in advanced T-cell lymphomas 2 2 −19.27, −8.04 No
DVL3 Disheveled, dsh homolog 3 1 −8.09 No
LRP5 Low-density lipoprotein receptor-related protein 5 1 −16.42 No
APC Adenomatous polyposis coli 1 −11.51 No
PRKACA Protein kinase, cAMP-dependent, catalytic α 1 −12.16 No
NFAT5 Nuclear factor of activated T-cell 5 2 −12.43, −8.84 No
FZD7 Frizzled family receptor 7 1 −13.9 No
CREBBP CREB binding protein 1 −10.29 No
CCND1 Cyclin D1 1 −13.9 No
PRICKLE2 Prickle homolog 2 3 −16.17, −15.12, −11.45 No
NFATC4 Nuclear factor activated of T-cells, cytoplasmic, calcineurin-dependent 4 1 −8.07 No
ROCK1 Rho-associated, coiled-coil containing protein kinase 1 2 −11.35, −8.53 No
CCND2 Cyclin D2 1 −9.2 No
CAMK2G Calcium/calmodulin-dependent protein kinase II γ 1 −10.98, −9.19 No
DVL2 Disheveled, dsh homolog 2 1 −11.46 No
aTarget prediction was performed using the PITA (https://genie.weizmann.ac.il) and TargetScan (http://www.targetscan.org) platforms.
bOnly the potential interaction sites with a ΔΔG ≤ 8 are were considered.
cΔΔG values were calculated using PITA.
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during macrophage infection of healthy individual and that of 
individual with active disease. However, whether the opposite 
regulation of these two miRNAs by the Beijing M. tuberculosis 
is hallmark of the virulence phenotype remain to be determined. 
Nonetheless, it is clear that the regulation of miRNAs expression 
by M. tuberculosis constitutes a novel mechanism to modulate the 
Wnt pathway during infection and also that through modulat-
ing the levels of specific miRNAs, the Wnt pathway ensures the 
macrophage infection with M. tuberculosis and its survival by 
promoting a anti-inflammatory environment.
CONCLUDiNg ReMARKS
In the course of M. tuberculosis infection, several pathways are 
induced to promote inflammation to eliminate the pathogen 
and to attenuate the inflammatory response to avoid tissue 
damage. The data discussed above strongly suggest that the 
Wnt signaling pathway plays a key role at different stages of TB 
development, including M. tuberculosis survival in the mac-
rophages, modulation of the inflammatory response, and later 
on granuloma formation and to control the adaptive immune 
response. However, further research is required to determine: (i) 
whether M. tuberculosis can directly activate the Wnt signaling 
pathway upon macrophage infection; (ii) which of the biologi-
cal effects attributed to cytokines are mediated by Wnt factors; 
(iii) whether virulent strains are more dependent on the Wnt 
pathway to ensure infection; and (iv) define how the different 
miRNAs expressed in response to M. tuberculosis infection 
modulate the Wnt signaling pathway, among other important 
processes. Efforts to determine the mRNA and miRNAs pro-
file of infected macrophages obtained from mouse or human 
granulomas using deep sequencing will provide a clear picture 
of which Wnt factors, FZD receptors, and Wnt-dependent genes 
are expressed among them miRNAs, the pathway targeted by 
these miRNAs and if all of this depend on the M. tuberculosis 
strain, the virulence or drugs resistance. This information may 
identify candidates for the development of new therapeutic 
strategies to promote mycobacterial destruction in the granu-
loma. Likewise, future clinical studies may provide new insights 
for therapeutic applications of Wnt factors.
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